Paclitaxel Injection Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL, 500 mg/83.3 mL

Reference Brands: Taxol(US & EU)

Category: Oncology Cancer Care

Paclitaxel Injection (30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL, and 500 mg/83.3 mL) is a chemotherapy drug used to treat cancers like breast cancer, ovarian cancer, and non-small cell lung cancer (NSCLC). Available in both the U.S. and EU, it works by inhibiting cancer cell division through IV infusion. A key product for oncology B2B distribution, it is essential for effective cancer treatment in hospitals and oncology centers. Paclitaxel Injection is available in Injection and strengths such as 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL, 500 mg/83.3 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Paclitaxel Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Paclitaxel Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Paclitaxel Injection 30 mg/5 mL, 100 mg/16.7 mL, 300 mg/50 mL, and 500 mg/83.3 mL is a vital chemotherapy drug used in the treatment of breast cancer, ovarian cancer, non-small cell lung cancer (NSCLC), and other cancers. Approved in both the U.S. and EU, Paclitaxel is administered via IV infusion and acts by disrupting microtubule formation, inhibiting cancer cell division. Available in various strengths, it is a cornerstone drug for oncology centers and hospitals. This makes it a key product in oncology B2B distribution, ensuring effective cancer treatment for a wide range of malignancies.